INFERGEN
Infergen is a small organization in the commercial physical research companies industry located in Lugano, Switzerland.
INFERGEN
Industry:
Biotechnology Commercial Medical
Founded:
2005-01-01
Address:
Lugano, Ticino, Switzerland
Country:
Switzerland
Status:
Active
Contact:
+41 919603727
Similar Organizations
Andreas Schenzle, Foodtechpal
Andreas Schenzle , Foodtechpal is a commercial physical research company located in Zurich.
More informations about "Infergen"
Report on New Patented Drugs โ Infergen - pmprb-cepmb.gc.ca
Report on New Patented Drugs โ Infergen. Under its transparency initiative, the PMPRB publishes the results of the reviews of new patented drugs by Board Staff, for purposes of โฆSee details»
Organization | Kadmon
Organization Overview. First Clinical Trial. 2009 NCT00086528. First Marketed Drug. 2009 interferon alfacon-1 . First NDA Approval. 2021 belumosudil . Last Known Activity. 2022 โฆSee details»
Infergen: Package Insert / Prescribing Information - Drugs.com
Interferons as Therapeutic Agents for Infectious Diseases
A low-dose oral version is in development for use in the treatment and prevention of influenza. 9 Both versions have been studied against human immunodeficiency virus (HIV)-1 infection, but โฆSee details»
Infergen Jan 12 2011 - pdf.hres.ca
Infergen® (Interferon alfacon-1) is a recombinant, non-naturally occurring type-I interferon. Infergen® differs from interferon alfa-2 at 20/166 amino acids (88% homology) and โฆSee details»
Interferon alfacon-1 - pharmacodia.com
Interferon alfacon-1 was first approved by the U.S. Food and Drug Administration (FDA) on October 6, 1997, then approved by European Medicine Agency (EMA) on February 1, 1999. It โฆSee details»
Infergen Stimulated Macrophages Restrict Mycobacterium โฆ
Dec 21, 2016 IFN alfacon-1 (Infergen) is a synthetic form of Interferon (IFN)-ฮฑ2b. Infergen has immunomodulatory activity and is effective against hepatitis C virus.However, the effect of โฆSee details»
Infergen medication guide - fda.report
Take INFERGEN exactly as your healthcare provider tells you. Too little INFERGEN may not be effective in treating your HCV infection and too much INFERGEN may cause side effects. โข โฆSee details»
INFERGEN® (Interferon alfacon-1) - DailyMed
Infergen causes โflu-likeโ symptoms in most patients. Symptoms include headache, muscle aches, tiredness, chills and fever that usually lessen after the first few weeks of therapy. If you inject your Infergen dose at bedtime, you โฆSee details»
Reference ID: 3309417 - Food and Drug Administration
Interferon therapy should not be treated with INFERGEN therapy 15 mcg three times a week. 2.2 Combination Treatment with INFERGEN/Ribavirin Dosing . The recommended dose of โฆSee details»
Peginterferon alfacon-1 - DrugBank Online
Nov 18, 2007 Identification Generic Name Peginterferon alfacon-1 DrugBank Accession Number DB05860 Background. PEGylation is a technology for the chemical attachment of polyethylene โฆSee details»
This label may not be the latest approved by FDA. For current โฆ
Interferon therapy should not be treated with INFERGEN therapy 15 mcg three times a week. 2.2 . Combination Treatment with INFERGEN/Ribavirin Dosing . The recommended dose of โฆSee details»
Infergen (InterMune), Drug Reference Encyclopedia
INFERGEN is a sterile, clear, colorless, preservative-free liquid formulated with 100 mM sodium chloride and 25 mM sodium phosphate at pH 7.0 ± 0.2. The product is available in single-use โฆSee details»
Infergen | Uses, Dosage, Side Effects, FAQ - MedicinesFAQ
Jul 1, 2021 Infergen is a recombinant non-naturally occurring type-I interferon. The 166-amino acid sequence of Infergen was derived by scanning the sequences of several natural โฆSee details»
Infergen (Interferon Alfacon-1): Side Effects, Uses, Dosage ... - RxList
Mar 1, 2022 Description for Infergen. Interferon alfacon-1 is a wholly synthetic type-I interferon. The 166-amino acid sequence of interferon alfacon-1 was derived by scanning the sequences โฆSee details»
Interferon alfacon-1: Uses, Interactions, Mechanism of Action ...
Jun 13, 2005 Infergen: Solution: 0.03 mg / mL: Subcutaneous: Three Rivers Pharmaceuticals Ltd: 1999-07-12: 2012-10-31: Canada: Categories ATC Codes L03AB09 โ Interferon alfacon โฆSee details»
Infergen Dosage Guide - Drugs.com
Dec 13, 2023 Table 3. Guidelines for Dose Modification or Discontinuation of INFERGEN/Ribavirin for the Management of Anemia* * For adult patients with a history of โฆSee details»
Infergen medication guide - Lexicomp Online
INFERGEN may cause eye problems that may lead to vision loss or blindness. You should have an eye exam before you start taking INFERGEN. If you have eye problems or have had them โฆSee details»
Infergen - Side Effects, Uses, Dosage, Overdose, Pregnancy
Nov 8, 2013 Infergen is a prescription medication used to treat lasting (chronic) hepatitis C virus (HCV) infection in adults. Infergen belongs to a group of drugs called synthetic interferons. โฆSee details»
INFERGEN (Interferon Alpha) Infergen (Interferon Alfaconโ1) โฆ
Aug 30, 2017 Both Infergen and Intron A are indicated for treatment of chronic hepatitis C in patients 18 years and older. Intron A is indicated for the treatment of hepatitis B. Intron A is โฆSee details»